5-Methoxytryptamine

CAS No. 608-07-1

5-Methoxytryptamine( 3-(2-Aminoethyl)-5-methoxyindole | O-Methylserotonin )

Catalog No. M20020 CAS No. 608-07-1

5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 26 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-Methoxytryptamine
  • Note
    Research use only, not for human use.
  • Brief Description
    5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
  • Description
    5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-(2-Aminoethyl)-5-methoxyindole | O-Methylserotonin
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    608-07-1
  • Formula Weight
    190.24
  • Molecular Formula
    C11H14N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:200 mM
  • SMILES
    COc1ccc2[nH]cc(CCN)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bacon WL et al. 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther. 2000 Aug;294(2):672-9.
molnova catalog
related products
  • AC-90179 HCl

    AC-90179 HCl is a selective inverse agonist of 5-HT2A receptor. AC-90179 HCl is an atypical antipsychotic pharmaceutical and has been shown to alleviate hallucinogen-induced vasocontriction.

  • Palonosetron hydroch...

    Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).

  • Lafutidine

    Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.